Ancure Stent
18,000 patients trusted the Ancure Endograft Stent to protect them from the dangers of open heart surgery. They never imagined that nearly 1 out of every 3 stents would fail leaving them vulnerable to leaks, aneurysms, ruptures and subject to follow-up surgeries and even death.
The Ancure Endograft stent system was approved by the FDA as an alternative treatment for abdominal aortic aneurysms. The stent promised a safer, less painful and less invasive method of treatment than the open-body alternatives like open-heart surgery.
The Guidant Corporation, makers of the Ancure Endograft stent system, knowingly covered up the many serious consequences of implanting Ancure stents including:
- A failure rate of nearly 33% worldwide
- At least 75 patients killed
- At least 1,000 patients injured
- Severe vessel damage caused by the stent delivery device, leading to leaks, aneurysms and ruptures
- The need for more invasive follow-up surgeries including open heart surgery
- Extended hospitalizations
If you or a loved one have been injured by a defective Ancure Stent please call us at (800) 411-0520 or fill out the form for immediate attention to your case.
